Skip to main content

Table 3 Incidence of cardiovascular disease death among tertile groups with different circulating PSM levels

From: Circulating palmitoyl sphingomyelin levels predict the 10-year increased risk of cardiovascular disease death in Chinese adults: findings from the Da Qing Diabetes Study

 

Group 1

Group 2

Group 3

P value

All participants, n

170

168

167

 

 PSM, µg/ml

5.98 (5.02–6.68)

9.06 (8.35–10.04)

25.74 (13.41–36.83)

< 0.001

 Incidence per 1000 person-years (95% CI)

7.8 (4.6–13.2)

13.7 (9.0–21.1)

38.7 (29.5–50.8)

 < 0.001

Individuals with diabetes, n

95

95

96

 

 PSM, µg/ml

6.23 (5.11–7.53)

10.35 (9.56–11.11)

33.85 (24.08–44.03)

< 0.001

 Incidence per 1000 person-years (95% CI)

14.7 (8.8–24.0)

24.8 (16.5–36.3)

41.5 (31.6–53.2)

 < 0.001

Individuals without diabetes, n

73

73

73

 

 PSM, µg/ml

5.23 (4.39–6.07)

8.03 (7.29–8.68)

14.02 (10.14–25.33)

 < 0.001

 Incidence per 1000 person-years (95% CI)

2.9 (0.7–11.0)

4.2 (1.4–12.4)

22.2 (14.0–34.2)

 < 0.001

  1. PSM palmitoyl sphingomyelin, CI confidence interval